REG - Directa Plus PLC - Notice of AGM

Directa PlusAnnouncement

03/06/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240603:nRSC7485Qa&default-theme=true

RNS Number : 7485Q  Directa Plus PLC  03 June 2024

3 June 2024

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

Notice of AGM

 

Directa Plus (AIM: DCTA), a leader in the production of pristine graphene
nanoplatelets for use in consumer and industrial markets through a unique and
patented chemical-free process, announces its Annual General Meeting ("AGM")
will be held at 3pm on Thursday, 27 June 2024 at 7th Floor, 50 Broadway,
London SW1H 0DB for which the Notice of AGM will today be posted to
shareholders and available on the Company's website
at: https://www.directa-plus.com/financial-results/
(https://www.directa-plus.com/financial-results/) .

 

The Annual Report and Accounts for the financial year ended 31 December 2023
will not be laid before the shareholders at the AGM, due to a delay in
finalising the audit process and signing the accounts. The Company intends to
announce its results for the year ended 31 December 2024 in June 2024,
following which the Company will convene a General Meeting at which the
receipt of the Annual Report and Accounts and the reappointment of auditors
will be put to shareholders.

 

Shareholders who wish to attend the AGM should register for the event in
advance by contacting directaplus@almastrategic.com
(mailto:directaplus@almastrategic.com) .

 

For further information, please contact:

 

 Directa Plus plc                                                        +39 02 36714458
 Giulio Cesareo, CEO
 Giorgio Bonfanti, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)  +44 131 220 6939
 Neil McDonald
 Adam Rae

 Singer Capital Markets Securities Limited (Joint Broker)                +44 20 7496 3069
 Rick Thompson
 Phil Davies

 Alma Strategic Communications (Financial PR Adviser)                    +44 20 3405 0205
 Justine James                                                           directaplus@almastrategic.com
 Hannah Campbell
 Kinvara Verdon

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and
suppliers of graphene-based products for use in consumer and industrial
markets. The Company's graphene manufacturing capability uses proprietary
patented technology based on a plasma super expansion process. Starting from
natural graphite, each step of Directa Plus' production process - expansion,
exfoliation and drying - creates graphene-based materials and hybrid graphene
materials ready for a variety of uses and available in various forms such as
powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene
nano-platelets. The products (marketed as G+(R)) have multiple applications
due to its properties. These G+(R) products can be categorised into various
families, with different products being suitable for specific practical
applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
Directa Plus holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAEAPKAESELEFA